5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.97▼ | 1.97▼ | 1.98▼ | 2.04▼ | 1.73▲ |
MA10 | 1.97▼ | 1.98▼ | 2.05▼ | 1.93▲ | 1.59▲ |
MA20 | 1.96▲ | 2.07▼ | 2.08▼ | 1.79▲ | 1.52▲ |
MA50 | 1.99▼ | 2.10▼ | 1.99▼ | 1.54▲ | 2.49▼ |
MA100 | 2.05▼ | 1.98▼ | 1.88▲ | 1.52▲ | 5.14▼ |
MA200 | 2.09▼ | 1.86▲ | 1.68▲ | 2.09▼ | 11.83▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.002▲ | -0.013▼ | -0.029▼ | 0.025▲ | 0.162▲ |
RSI | 45.562▼ | 35.737▼ | 40.478▼ | 58.446▲ | 52.650▲ |
STOCH | 60.979 | 12.544▼ | 5.269▼ | 72.994 | 75.701 |
WILL %R | -55.556 | -89.796▼ | -92.857▼ | -44.496 | -23.467▲ |
CCI | 36.176 | -72.393 | -76.907 | 68.817 | 187.709▲ |
Friday, June 13, 2025 03:18 PM
Shares of JBS posted a slight gain in their NYSE debut Friday after years of complications for the Brazilian meatpacking giant to trade in U.S. public markets.
|
Wednesday, May 28, 2025 02:23 AM
In this article, we are going to take a look at where Editas Medicine, Inc. (NASDAQ:EDIT) stands against the other CRISPR stocks. The pharmaceutical industry is buzzing with innovation ...
|
Sunday, May 25, 2025 03:38 AM
Editas Medicine (NASDAQ: EDIT), a gene-editing-focused clinical-stage biotech, is firmly in the speculative camp, which is why its shares are down by 97% since early 2021. The stock is trading for ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 2.02 | 2.1152 | 1.94 | 1.97 | 3,051,468 |
12/06/25 | 2.05 | 2.295 | 1.9706 | 2.18 | 3,205,125 |
11/06/25 | 2.10 | 2.19 | 2.0125 | 2.03 | 2,013,087 |
10/06/25 | 1.975 | 2.22 | 1.93 | 2.105 | 2,798,643 |
09/06/25 | 1.98 | 2.02 | 1.845 | 1.93 | 1,222,385 |
06/06/25 | 1.81 | 1.97 | 1.80 | 1.91 | 2,451,101 |
05/06/25 | 1.80 | 1.98 | 1.73 | 1.80 | 3,177,198 |
04/06/25 | 1.82 | 1.85 | 1.77 | 1.82 | 866,163 |
03/06/25 | 1.75 | 1.87 | 1.66 | 1.82 | 1,658,541 |
02/06/25 | 1.76 | 1.92 | 1.75 | 1.77 | 2,166,579 |
|
|
||||
|
|
||||
|
|